EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies

Bahareh Farasati Far iD, Kimia Omidvar, Ehsan Heidari, Mina Ebrahimi, Yasaman Mohammadi, Yavuz Nuri Ertas iD

ACS Pharmacology & Translational Science · 09.01.2026 · 9 (1) · 1-19

DOI: 10.1021/acsptsci.5c00407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 26.12.2025. Verfasst von Bahareh Farasati Far und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Erciyes University, Kayseri 38039, Türkiye. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

high-throughput neuropharmacologyiPSC-derived brain organoidsneuronal engineeringneuron−glia coculturesneuropsychiatric drug discoveryprecision neuropsychiatry

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Erciyes University, Kayseri 38039, Türkiye.
  • Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran 1333795914, Iran.
  • Department of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California 94305, United States.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan 45139-56184, Iran.
  • Faculty of Dentistry, Islamic Azad University, Shiraz Branch, Shiraz 71987-74731, Iran.

ORCID-Profile: Bahareh Farasati Far, Yavuz Nuri Ertas

Zitieren

APA

Farasati Far, B., Omidvar, K., Heidari, E., Ebrahimi, M., Mohammadi, Y., & Ertas, Y. N. (2026). Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies. ACS Pharmacology & Translational Science, 9(1), 1-19. https://doi.org/10.1021/acsptsci.5c00407

Vancouver

Farasati Far B, Omidvar K, Heidari E, Ebrahimi M, Mohammadi Y, Ertas YN. Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies. ACS Pharmacology & Translational Science. 2026;9(1):1-19. doi:10.1021/acsptsci.5c00407

BibTeX
@article{FarasatiFar2026,
  author = {Farasati Far, Bahareh and Omidvar, Kimia and Heidari, Ehsan and Ebrahimi, Mina and Mohammadi, Yasaman and Ertas, Yavuz Nuri},
  title = {Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1--19},
  doi = {10.1021/acsptsci.5c00407}
}
Kostenlos starten →